FDA Moves Hyrnuo (sevabertinib) Into First-Line Therapy for HER2-Positive NSCLC
0:46
FDA Moves Hyrnuo (sevabertinib) Into First-Line Therapy for HER2-Positive NSCLC
21 views1 month ago
YouTubeGO2 for Lung Cancer
What drives KRAS G12C–mutant NSCLC response to immunotherapy?
0:20
What drives KRAS G12C–mutant NSCLC response to immunotherapy?
418K views2 months ago
YouTubeLilly Medical
Treatment Algorithm: Metastatic NSCLC W/O Targeted Mutations with Dr. Christine Garcia
1:20
Treatment Algorithm: Metastatic NSCLC W/O Targeted Mutations with Dr. Christine Garcia
482 views5 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discussions
How well do you understand the clinical biology of NSCLC and CSCC?
0:15
How well do you understand the clinical biology of NSCLC and CSCC?
7 views2 months ago
YouTubeONCOassist
Combining KRAS Inhibition With Immunotherapy in #NSCLC
1:01
Combining KRAS Inhibition With Immunotherapy in #NSCLC
153 views6 months ago
YouTubeTargeted Oncology
Understanding Biomarkers in NSCLC
1:28
Understanding Biomarkers in NSCLC
787 viewsAug 18, 2025
YouTubeAbbVie US
Osimertinib plus Chemotherapy in EGFR-Mutated NSCLC (FLAURA2)
2:09
Osimertinib plus Chemotherapy in EGFR-Mutated NSCLC (FLAURA2)
2.3K views3 months ago
YouTubeNEJM Group
0:20
Many patients with KRAS G12C–mutant NSCLC may never advance to 2L therapy
853.1K views3 months ago
YouTubeLilly Medical
1:00
Non Small Cell Lung Cancer: Comprehensive Biomarker Testing is Non Optional
136 views4 months ago
YouTubeMD Newsline
1:10
Treatment Algorithm: Focused discussion around BRAF-V600E metastatic NSCLC with Dr. Gregory Riely
307 views4 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discussions
1:23
EGFR Inhibitors for NSCLC
23 views3 months ago
YouTubeCancerCare
0:32
KRAS G12C Differs from Other Variants
5 views1 month ago
YouTubeLilly Medical
1:02
I was SHOCKED at my Lung Cancer Diagnosis! (Biomarker testing for lung cancer treatment)
4.6K views4 months ago
YouTubeThe Patient Story
1:31
I was ALONE when I found out my Lung Cancer was STAGE 3
14.3K views7 months ago
YouTubeThe Patient Story
1:06
New FDA Approval | Hernexeos (zongertinib) for HER2-Mutated Non-Small Cell Lung Cancer (NSCLC)
271 views7 months ago
YouTubeGO2 for Lung Cancer
0:31
GSK Ends Cobolimab NSCLC Program After Mid-Stage Trial Results
136 viewsAug 14, 2025
YouTubeXtalks
1:01
The HER2 Diagnostic and Treatment Landscape in NSCLC
892 viewsApr 30, 2025
YouTubeOncBrothers: Practice-Changing Cancer Discussions
1:18
mRNA Lung Cancer Clinical Trial Recruiting! (INTerpath-009 Trial for NSCLC)
2 months ago
YouTubeDr. Rob Swanda
0:51
FDA Approval Jideytro (zidesamtinib) | Lung Cancer Awareness | Lung Cancer Treatment Update
111 views2 months ago
YouTubeGO2 for Lung Cancer
0:14
ERBB2: The Lung Cancer Driver You Need to Know
4 views6 months ago
YouTubeOncology Data Advisor
See more
Static thumbnail place holder